MBF Therapeutics Inc. Email Format

Biotechnology ResearchUnited States2-10 Employees

MBF Therapeutics is a United States–based biotechnology company developing vaccines for animal health, centered on a DNA-based immunotherapeutic platform. The platform aims to identify relevant pathogen antigens and deliver them in proprietary formulations to provoke strong T cell–driven immunity and durable protection. It seeks to overcome safety and efficacy limitations of traditional killed-virus and live-attenuated vaccines, with a focus on respiratory diseases that affect livestock.
The initial emphasis is on economically impactful swine diseases such as Porcine Reproductive and Respiratory Syndrome and African Swine Fever. In addition to veterinary applications, the company notes translational opportunities in human health and operates within the biotechnology research sector with a small team headquartered in the United States.

Sign up for free to view info

Company overview Employee directory